Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology business, is pleased to announce that its new global digital medical education programme has been accredited by the Royal College of Surgeons of England.

Launched in March 2020 in response to the COVID-19 pandemic, the programme is designed to support the development of surgeons by providing educational webinars on the safe and effective use of Smith+Nephew products as well as surgical techniques.

Over the course of the initial month since launch, the programme has attracted healthcare professionals from more than 110 different countries, with attendance between 400 and 850 per event. In total, more than 11,000 healthcare professionals have attended to hear from industry leading experts on a wide range of topics relevant to both our Orthopaedics and Sports Medicine Franchises.

Accreditation from the Royal College of Surgeons of England enables delegates to receive Continuing Professional Development (CPD) credit for each webinar they attend.

Cynthia Walker, Senior Vice President Medical Education at Smith+Nephew, said:

'To successfully provide our medical education programme online and be delivering courses regularly attended by thousands of surgeons in just a few weeks is an incredible achievement. Being endorsed by the Royal College of Surgeons of England is an important validation and we are grateful for their guidance and support.'

This accreditation builds on the Royal College of Surgeons of England accreditation received in 2018 for Smith+Nephew's surgical training facility, the Expert Connect Centre, in Watford, UK.

Enquiries

Media

Charles Reynolds

Smith+Nephew

+44 (0)7811 121398

Francesca Dunning

+44 (0)7583 003884

Smith+Nephew

About Smith+Nephew

Smith+Nephew is a portfolio medical technology business that exists to restore people's bodies and their self-belief by using technology to take the limits off living. We call this purpose 'Life Unlimited'. Our 17,500+ employees deliver this mission every day, making a difference to patients' lives through the excellence of our product portfolio, and the invention and application of new technologies across our three global franchises of Orthopaedics, Advanced Wound Management and Sports Medicine & ENT.

Founded in Hull, UK, in 1856, we now operate in more than 100 countries, and generated annual sales of $5.1 billion in 2019. Smith+Nephew is a constituent of the FTSE100 (LSE:SN, NYSE:SNN). The terms 'Group' and 'Smith+Nephew' are used to refer to Smith & Nephew plc and its consolidated subsidiaries, unless the context requires otherwise.

For more information about Smith+Nephew, please visit www.smith-nephew.com and follow us on Twitter, LinkedIn, Instagram or Facebook.

About the Royal College of Surgeons

The Royal College of Surgeons of England is a professional membership organisation and registered charity, which exists to advance surgical standards and improve patient care.

For more information, visit https://www.rcseng.ac.uk/ or to speak to a member of the Press Office, Telephone: 020 7869 6047/6052, or email: pressoffice@rcseng.ac.uk.

(C) 2020 Electronic News Publishing, source ENP Newswire